BioMedNewsBreaks – United Medical Equipment Business Solutions Network Inc.’s Test Identifies Acute COVID-19 Infection with High Sensitivity, Specificity

United Medical Equipment (“UME,” “UMEBSNI”) has made significant progress in helping the world curb the spread of COVID-19. An article on United Medical’s successes reads, “As the world attempts to control this pandemic, it is essential to quickly identify who is infected and who has already been infected. Antibody testing determines whether or not a patient has had COVID-19 in the past, while antigen testing determines whether or not a patient currently has COVID-19… Antibody tests have limited use in detection but help to determine the accurate case numbers and research into immunity.” On the other hand, antigen rapid tests are beneficial. “The antigen rapid test allows for quick diagnosis that can help curb the spread of the virus… The FDA-approved CareStart(TM) COVID-19 Antigen Rapid POC test is part of UME’s answer in combating the spread of the virus… This test identifies acute infections with 88.4% sensitivity and 100% specificity, and helps provide critical answers about active infections to patients and healthcare workers alike.”

To view the full article, visit https://ibn.fm/RKx0f

About United Medical Equipment Business Solutions Network Inc.

United Medical Equipment Business Solutions Network offers reliable resources and solutions that are designed to meet the ever-changing needs of an aging population, which includes seniors and veterans. The company’s owners and founders bring decades of combined business, military and cardiovascular critical care nursing experience. United Medical Equipment understands the needs and concerns of the aging population, including veterans and their families, and offers the support, solutions and reliable information critical in making informed decisions. UMEs’ mission is to provide guidance for caregivers, veterans, the aging population and medical community through its medication management and telehealth applications by providing reliable resources, products and support services designed to meet unique needs. For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to UME are available in the company’s newsroom at https://ibn.fm/UnitedMed

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection

HeartBeam (NASDAQ: BEAT) announced it has received FDA 510(k) clearance for its flagship ECG system,…

2 days ago

BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia

Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste…

4 days ago

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology 

HeartBeam (NASDAQ: BEAT), announced the issuance of two new U.S. patents that strengthen its intellectual…

4 days ago

BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the successful commercial manufacturing…

4 days ago

BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast

Intelligent Bio Solutions (NASDAQ: INBS) CEO Harry Simeonidis joined the latest episode of The BioMedWire…

5 days ago

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring

HeartBeam to integrate AccurECG(TM), AccurKardia’s FDA-cleared ECG analysis software Collaboration enhances HeartBeam’s commercial offering with…

5 days ago